MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...
TAIPEI, Jan. 30, 2026 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) today announced that its Board of Directors has ...
Protests against ICE in Minneapolis, war-damaged bridges in Syria, a landslide in Sicily, a heat wave in Australia, heavy ...